eVTOL trading stayed highly selective on May 12: Joby closed at $10.49 on 27,975,454 shares, Archer closed at $6.39 on 54,266,111 shares, and EHang closed at $9.85 on 756,451 shares. The market is not treating those numbers as equal signals, because investors are rewarding the clearest near-term certification headline, discounting the most capital-intensive scaling model, and still placing a geography and trust penalty on the operator with the most visible commercial deliveries.
Macro data (10Y yield, fed funds) was unavailable this run.
For today’s detailed market data, see Joby Daily, Archer Daily, and EHang Daily.
Is Archer’s FAA momentum now outranking Joby’s stronger balance sheet in the market’s pecking order?
The simplest way to read today’s cross-company setup is that investors are paying for immediacy. Archer’s headline is easy to understand: it said it became the first eVTOL company to close Phase 3 of the FAA’s four-phase type-certification process and still expects initial U.S. operations in 2026, according to Archer’s May 11 operating update. Joby’s case is broader and arguably stronger in substance, but it is less compressed into one tradable headline: the company reported about $2.5 billion in cash, flew its first FAA-conforming aircraft for TIA work, completed its SR3 audit, and said composite production is running at more than 2.5 times last year’s volume in its first-quarter shareholder update.
That difference helps explain why ETF optics currently favor Archer. ARKX held Archer at 4.05% (5,812,987 shares) as of May 10, 2026; no new trade-level data was retrieved. ARKX held Joby at 2.81% (2,409,438 shares) as of May 10, 2026; no new trade-level data was retrieved. On the tape, Archer also drew roughly 54.3 million shares of volume versus Joby’s 28.0 million, which tells me capital was reacting more aggressively to the certification narrative than to pure balance-sheet depth. The way I see it, that is not a statement that Archer is the better business today. It is a statement that the market still discounts future milestones by how legible they are, not by how many strategic advantages are bundled together in one quarter.
There is an important nuance here. Joby’s advantages are cumulative: cash, manufacturing scale-up, New York flight visibility, and a clearer integrated-service ambition. Archer’s advantage is sequential: one more regulatory step closed, one more reason to believe commercialization can become concrete. Sequential stories often trade better than cumulative stories when a sector is still pre-scale, because investors are trying to map the next catalyst rather than the full terminal value. That is why Archer can attract a narrative premium even while its latest quarter also carried an earnings miss and a wider loss profile, with MarketBeat noting EPS of negative $0.28 versus a negative $0.25 consensus and revenue of $1.60 million versus $1.66 million expected in its May 12 recap of the print.
FAA certification data was unavailable this run; next check scheduled for 2026-05-14.
My read is constructive on Archer tactically but still more balanced strategically. If the sector remains headline-driven, Archer can keep outperforming on certification clarity alone. If investors rotate back toward durability, funding capacity, and execution breadth, Joby’s stronger balance sheet should reassert itself quickly. So yes, the market is ranking visible FAA momentum above stronger liquidity right now, but I do not think that ranking is permanent; it looks catalyst-sensitive rather than thesis-settling.
Can Joby’s current production ramp really support a TaaS scale story without more dilution?
This is where the most ambitious narrative in the group starts to collide with capital reality. Joby’s first-quarter update is credible on operating progress: about $2.5 billion in cash, more than 2.5 times last year’s composite output, first conforming propeller-blade production in Ohio, and parts already in production for eight additional aircraft including the remaining FAA-conforming aircraft slated for TIA. That is real industrial preparation, not slideware. But the equity story investors are being asked to underwrite is much larger than near-term certification. The long-range scenario circulating in the collected source set points to revenue of $111 million in 2026, $2.24 billion in 2030, and $11.0 billion in 2034, while also noting that the share count has already expanded from roughly 604 million around the IPO period to more than 900 million.
I think that gap matters more than today’s bullish framing admits. A transportation-as-a-service model can create stronger long-run economics than a pure OEM model if utilization, route density, maintenance efficiency, and pricing all line up. But it is also the hungrier model because the operator has to fund aircraft deployment, infrastructure coordination, operating staff, maintenance systems, and launch-market buildout before the network reaches efficient scale. An aircraft seller can hand off capital intensity to customers. A TaaS platform retains more of it on its own balance sheet.
That makes Joby’s current war chest impressive but not automatically sufficient. Even if the company reaches early operations without another major equity raise, the leap from $111 million to $2.24 billion in four years implies a very fast conversion of certification progress into deployed aircraft, active routes, and repeated passenger usage. Nothing in today’s disclosed manufacturing cadence proves that jump is impossible, but nothing proves it can be financed cleanly either. Producing parts for eight additional aircraft is a useful marker of readiness; it is not yet evidence of a capital-light scaling machine. The old market habit of treating every production update as if it solves downstream funding math is too generous for a business model this infrastructure-heavy.
My view is cautious rather than dismissive. Joby has more room than most peers to absorb delays because the cash balance is so large and because its integrated model could produce a higher-quality moat if it works. The problem is that dilution is still part of the base case, not just the bear case. Investors should remember that even very strong aviation and mobility platforms rarely scale in a straight line, and a TaaS system adds operating complexity on top of certification complexity. If utilization ramps slower than expected or city-by-city deployment stretches out, the financing burden comes back into focus quickly.
So the directional lean here is cautious. Joby looks capable of moving the TaaS model from concept toward early commercial reality with existing capital, and that is meaningful progress. I do not yet see enough evidence to say it can reach 2030-style revenue scale without additional dilution or fresh financing, which means the stock still deserves a discount for execution depth even while the company deserves credit for real manufacturing momentum.
Why does EHang still sit outside visible U.S. institutional flow even after proving more real deliveries and revenue?
EHang’s numbers are the most awkward for the U.S. market narrative because they force investors to separate operating proof from investable comfort. In the third-party sector roundup collected today, EHang was described as having delivered 221 units in fiscal 2025, generated about $73 million of revenue, and produced its first GAAP-profitable quarter in Q4 in a May 12 sector article from Primary Ignition. Those are not trivial milestones in an industry where many public peers are still defined more by certification promises than by deliveries. Yet the ARKX snapshot that visibly highlights Archer at 4.05% and Joby at 2.81% does not show EHang among the leading disclosed weights, which means the company remains outside the most visible U.S. thematic capital channel being tracked in this workflow.
The reason, in my judgment, is that U.S. investors are not only buying proof of demand. They are buying a package of regulatory familiarity, geographic trust, and narrative portability. Joby and Archer both map directly into the U.S. framework that institutions prefer to model: FAA-linked certification progress, domestic city-launch stories, U.S. partnerships, and English-language investor messaging that updates the same commercialization template every few weeks. EHang’s progress is real, but it is real inside a different validation regime. Its strongest evidence comes from Chinese certification and delivery activity, while much of its commercial traction still sits inside a China-centered low-altitude economy story that many U.S. funds either cannot underwrite comfortably or do not prioritize.
That is why revenue has not translated into equivalent sponsorship. The market is not saying EHang failed to execute. It is saying the execution is not yet portable enough. ADR structure discomfort, concentration of revenue in China, and the lack of a live FAA-centered narrative all widen the gap between operating accomplishment and U.S. fund adoption. The contrast with Archer is especially sharp: Archer can post weak near-term financials and still capture attention because Phase 3 completion instantly fits the decision framework of American growth investors. EHang can post better commercialization evidence and still be treated as peripheral because the evidence sits outside that same framework.
My read is skeptical on near-term U.S. fund-flow re-rating, even though the operating record deserves more respect than it gets. If EHang adds clearer Western-market relevance, broader cross-border certification credibility, or more visible institutional inclusion, the discount could close fast because the base metrics already look more commercial than many peers. Until then, the directional lean remains cautious-to-bearish for relative capital flows: EHang may continue proving the business while still failing to win the portfolio narrative that moves U.S. eVTOL money.
What to Watch Tomorrow
First, watch whether any fresh Archer disclosure turns Phase 3 language into a more concrete Phase 4 testing timeline, because that is the clearest trigger for extending its current narrative premium.
Second, watch whether Joby adds any new evidence on production throughput, aircraft count, or route economics, because the dilution debate becomes less severe only when manufacturing progress starts translating into visible commercialization math.
Third, watch whether EHang produces a catalyst that travels into a U.S. institutional framework, such as broader cross-market validation or new fund inclusion, because deliveries and revenue alone are not yet changing its capital-access story.
This is not financial advice. Do your own research.
Follow @futurewatchlog for daily eVTOL coverage.
Previous insight: https://futurewatchlog.com/2026/05/12/evtol-daily-insight-2026-05-12/